Montelukast-Based Premedication Regimen for Recurrent Cetuximab Infusion-Related Reactions.

IF 4.7 3区 医学 Q1 ONCOLOGY JCO oncology practice Pub Date : 2021-01-01 Epub Date: 2020-09-29 DOI:10.1200/OP.20.00103
{"title":"Montelukast-Based Premedication Regimen for Recurrent Cetuximab Infusion-Related Reactions.","authors":"Amy M Sion, Lyndsey Milburn, John M Kaczmar","doi":"10.1200/OP.20.00103","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":14612,"journal":{"name":"JCO oncology practice","volume":"17 1","pages":"54-56"},"PeriodicalIF":4.7000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1200/OP.20.00103","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JCO oncology practice","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1200/OP.20.00103","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/9/29 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
基于孟鲁司特的药物前方案治疗复发性西妥昔单抗输注相关反应。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
相关文献
Grade 3 infusion-related reaction because of cetuximab administered with 5-fluorouracil and cisplatin chemotherapy for a recurrent and metastatic head and neck cancer patient who received chlorpheniramine 5 mg, dexamethasone 13.2 mg, and aprepitant 125 mg premedication
IF 0 European Journal of Oncology PharmacyPub Date : 2020-01-01 DOI: 10.1097/OP9.0000000000000021
A. Horinouchi, Shinya Suzuki, T. Enokida, Hayato Kamata, A. Kaneko, C. Matsuyama, T. Fujisawa, Yuri Ueda, S. Okano, T. Kawasaki, M. Tahara
Albuterol-based premedication therapy for the prevention of cetuximab infusion-related reactions
IF 45.3 1区 医学Journal of Clinical OncologyPub Date : 2008-05-20 DOI: 10.1200/jco.2008.26.15_suppl.17040
F. Tra, M. Fesen, M. Pianalto, R. Nisly
Premedication and incidence of infusion-related reactions in patients with metastatic colorectal cancer treated with cetuximab plus irinotecan-based chemotherapy.
IF 45.3 1区 医学Journal of Clinical OncologyPub Date : 2010-05-20 DOI: 10.1200/JCO.2010.28.15_SUPPL.3561
H. Wilke, S. Siena, A. Loos, K. Berghoff, C. Köhne, E. Cutsem
来源期刊
CiteScore
6.40
自引率
7.50%
发文量
518
期刊最新文献
Changing What Can Be Changed: Validating Navigation as Essential Care in Modern Oncology. Disparities in Endometrial Cancer Mortality: Will Increasing Use of Targeted Therapies Widen the Gap? Trends in Outpatient Opioid Prescriptions for Cancer Pain Between 2016 and 2021. Treatment Patterns, Trends, and Outcomes of Neoadjuvant Chemotherapy Use Among Patients With Early-Stage Invasive Triple-Negative Breast Cancer. Housing-Related Disparities in Receipt of Breast Cancer Screening Among Women Medicaid Beneficiaries.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1